SELECT-3: a phase I study of selumetinib in combination with platinum-doublet chemotherapy for advanced NSCLC in the first-line setting
scientific article published on 24 August 2017
Author/s
author:
Alastair Peter Greystoke,
Fiona Blackhall,
Raffaele Califano
Wikidata